Category: Dermatology

Onychorrhexis is a nail condition marked by vertical ridging and splitting of the nail plate, most often affecting the fingernails but sometimes the toenails as well. It is usually harmless and cosmetic, but it can also signal an underlying health issue or repeated nail damage.

What it is

The word onychorrhexis comes from Greek roots meaning “nail” and “bursting,” which fits the way the nail can look brittle and fractured. In simple terms, the nail grows with fine longitudinal grooves, may feel rough, and can break or peel more easily than normal. The condition is part of the broader group of brittle nail disorders, and clinicians often use it to describe the pattern of vertical ridging and splitting.

Causes and risk factors

Onychorrhexis can happen for many reasons, and aging is one of the most common. It may also be linked to repeated wetting and drying of the hands, frequent use of nail polish remover, nail biting or picking, and other external trauma to the nail plate. Nutritional problems and medical conditions such as iron-deficiency anemia, thyroid disease, eating disorders, fungal infection, psoriasis, lichen planus, rheumatoid arthritis, and some inherited skin disorders have also been associated with it.

A useful way to think about the condition is that the nail matrix, the tissue that makes the nail, may be affected by a disease or injury, producing a weaker nail as it grows. In that sense, onychorrhexis is often less a disease in itself than a visible sign of something else affecting nail formation.

Symptoms and appearance

The main sign is a series of vertical ridges running from the base of the nail toward the tip. The nail may also become brittle, split at the free edge, chip easily, or develop a rough texture. Some people notice the changes on one nail, while others have them on multiple nails. Pain is uncommon, but deeper splits can sometimes be uncomfortable.

Onychorrhexis is often confused with other nail problems, but it is distinct from pitting, which consists of small dents in the nail surface. That difference matters because pitting points more strongly toward other diagnoses such as psoriasis, while ridging and splitting point more toward onychorrhexis.

Diagnosis

Diagnosis is usually clinical, meaning a doctor can often identify it by looking at the nails and asking about symptoms, habits, and medical history. Because the condition can reflect an underlying disorder, the important task is not only naming the nail change but also finding the reason it is happening. A clinician may ask about diet, medications, hair or skin changes, fatigue, menstrual history, and exposure to chemicals or water.

In some cases, testing may be used to look for anemia, thyroid problems, fungal infection, or other systemic illness if the nail findings suggest more than simple cosmetic change. This is especially relevant when the nail changes are sudden, severe, painful, or accompanied by other symptoms

Treatment and care

Treatment depends on the cause. If an underlying condition such as iron deficiency, thyroid disease, or a fungal infection is found, addressing that problem may improve the nails over time. If the issue is related to irritants or habits, reducing exposure to soap, water, solvents, and trauma can help. Moisturizing the nails and protecting the hands with gloves during cleaning or dishwashing are practical steps that may reduce further damage.

Some sources mention supplements or topical approaches in selected cases, but the most important principle is to treat the cause rather than the ridges alone. Nails grow slowly, so improvement usually takes weeks to months even after the trigger is removed.

Prevention and outlook

Prevention focuses on gentle nail care and minimizing repeated injury. That includes avoiding harsh nail products, keeping nails trimmed, limiting contact with water and chemicals, and maintaining good nutrition. For people with chronic skin or medical conditions, controlling the underlying disease can reduce recurrence.

The outlook is generally good because onychorrhexis is often harmless and manageable. Still, it should not be ignored if the change is new, worsening, or accompanied by pain, discoloration, fatigue, or other symptoms. In those cases, the nails may be providing an early clue to a broader health issue.

Onychorrhexis is therefore best understood as a sign rather than a single disease: a visible pattern of ridging and brittleness that may be caused by aging, environment, habit, or illness. Written this way, it shows how the nails can reflect the health of both the skin and the body as a whole.

Onychophosis is a localized buildup of thickened keratinous skin in or around the nail sulcus, most often near the great toenail, and it can range from mildly annoying to very painful. It is commonly linked to pressure, friction, nail curvature, tight footwear, adjacent toe deformity, and poor nail trimming technique.

Onychophosis

Onychophosis, also called onychoclavus in some sources, is a hyperkeratotic condition affecting the nail folds or nail groove. Clinically, it is often described as thickened skin developing between the nail plate and the surrounding nail folds, and it may be mistaken for an ingrown toenail or fungal nail disease. Although it can occur in different toes, the hallux is particularly common, and some references note involvement of the first and fifth toes more frequently.

Pathology and Causes

The condition develops when repeated mechanical stress causes the skin to thicken as a protective response. A curved or involuted nail can compress the nail sulcus, while tight shoes or toe crowding increase lateral pressure and aggravate the process. Structural foot issues such as hallux valgus or other toe deformities may contribute by altering load distribution and increasing friction. In older adults, age-related nail changes and reduced self-care may also make onychophosis more common.

Clinical Features

Patients may report tenderness along the side of the nail, pain with shoe pressure, or discomfort when trimming the nail. In some cases, the skin thickening is obvious and in others it is subtle and easily missed. Severe cases may show periungual inflammation, erythema, or swelling, especially if the area has become repeatedly irritated. The key clinical point is that the pain may mimic an ingrown toenail even when the nail is not actually embedded in the skin.

Differential Diagnosis

Onychophosis should be distinguished from an ingrown toenail, which involves true penetration of the nail edge into soft tissue. It may also be confused with onychomycosis, periungual callus, or a corn adjacent to the nail fold. Careful inspection of the nail plate shape, the groove, and the surrounding skin usually helps separate these conditions. In practice, a patient may have both onychophosis and early ingrowing nail features at the same time.

Management

Management focuses on reducing pressure and removing the hyperkeratotic tissue. Conservative care usually includes careful debridement or reduction of the thickened skin, appropriate nail cutting, and avoidance of pressure from footwear. If nail curvature is contributing, regular professional nail care can help prevent recurrence. Addressing biomechanical factors such as toe crowding or hallux valgus may also reduce ongoing irritation.

Prevention and Prognosis

Prevention is largely mechanical: roomy shoes, good nail trimming technique, and early treatment of nail-edge pressure can all reduce recurrence. Because the disorder is driven by repeated friction or compression, symptoms often recur if the underlying cause is not corrected. The prognosis is generally good, especially when the area is treated early and footwear or nail-care habits are modified. In long-standing cases, ongoing podiatric care may be needed to keep the condition comfortable and prevent progression.

Onychophosis is a common but under-recognized cause of periungual pain and nail-fold hyperkeratosis. It is usually driven by chronic pressure, nail shape, footwear, or toe deformity rather than infection, which makes accurate diagnosis important for effective treatment. For patients, the most helpful approach is often a combination of local reduction of callus, better nail care, and correction of the mechanical cause.

Onychomycosis of the toenails is a chronic fungal infection of the nail unit that commonly causes discoloration, thickening, brittle edges, subungual debris, and cosmetic concern. It is a frequent problem in clinical practice because toenails grow slowly, are often exposed to moist footwear environments, and are vulnerable to repeated trauma. Although the condition is not usually life-threatening, it can be uncomfortable, persistent, and socially distressing, and in higher-risk patients it may contribute to secondary complications such as skin breakdown or bacterial infection. Effective management depends on confirming the diagnosis, choosing treatment based on severity and organism type, and addressing factors that promote reinfection.

A major first step is ensuring that the nail change is truly fungal. Dystrophic nails can result from trauma, psoriasis, eczema, lichen planus, or age-related changes, and treating the wrong condition exposes the patient to unnecessary medication and delayed improvement. Because clinical appearance alone is not always reliable, confirmatory testing such as microscopy, culture, or other laboratory methods is often recommended before starting long courses of therapy. This is particularly important when the diagnosis is uncertain, when disease is extensive, or when systemic antifungal treatment is being considered.

The choice of treatment depends on the extent of disease, the number of nails involved, matrix involvement, patient preference, and comorbidities. For dermatophyte onychomycosis, oral terbinafine is widely regarded as the first-line therapy because it has high efficacy, relatively low relapse rates, and favorable cost-effectiveness. Typical treatment for toenails is 12 weeks. Oral itraconazole is another option, and fluconazole may be used in selected cases, especially when Candida species are involved or when other agents are not tolerated. Systemic therapy generally offers better cure rates than topical therapy, but it requires attention to contraindications, drug interactions, and potential hepatic or other adverse effects

Topical treatment has an important role, especially for mild or early disease. Topical agents such as efinaconazole, tavaborole, and ciclopirox can be useful when involvement is limited, when only a single nail is affected, or when the patient cannot take oral medication. However, topical therapy is usually less effective than oral treatment when used alone, largely because penetration through the nail plate is difficult. These agents often require prolonged daily use, sometimes for many months, and adherence can be challenging. For some patients, topical therapy is best used as an adjunct to oral treatment rather than as a standalone solution.

Mechanical care also matters. Regular trimming and debridement of thickened nails can reduce pressure, improve comfort, and allow topical medication to reach the nail better. In some cases, chemical or surgical nail avulsion may be considered, particularly when the nail is severely dystrophic or painful. Debridement does not cure the infection by itself, but it can improve functional outcomes and treatment tolerance. This is especially relevant in patients with very thick nails, where medication penetration is poor and routine footwear may become uncomfortable.

Patient education is a critical part of management because recurrence is common. The infection often persists in the surrounding skin, especially when tinea pedis is present, and reinfection from contaminated socks, shoes, or communal wet areas is frequent. Patients should be advised to treat any coexisting athlete’s foot, keep feet dry, change socks daily, use breathable footwear, and consider antifungal powders in shoes or on the feet when appropriate. Good nail hygiene, avoidance of sharing nail tools, and careful trimming of nails straight across can also help reduce ongoing trauma and spread

It is important to approach “natural” or home remedies cautiously. Some sources and anecdotal reports promote vinegar soaks, tea tree oil, or other household remedies, but these approaches generally have weaker evidence than prescription antifungal therapy and should not replace proven treatment in established onychomycosis. They may be used by some patients as adjuncts, but expectations should be realistic. In a patient with significant nail thickening or long-standing disease, relying on unproven remedies alone often leads to prolonged infection and frustration.

Certain patients need more careful assessment. Individuals with diabetes, peripheral vascular disease, neuropathy, or immunosuppression may be at higher risk of complications and may benefit from earlier systemic treatment and closer follow-up. In these groups, chronic nail infection can contribute to skin injury, discomfort with walking, and secondary bacterial problems. For patients taking multiple medications, checking interactions is essential before prescribing oral antifungals. In practice, the treatment plan should be individualized rather than applied as a one-size-fits-all approach.

Follow-up is another important part of care because improvement is slow. Toenails grow gradually, so visible normalization may take many months even after successful therapy. Patients should be counseled that the nail does not look normal immediately, and that treatment success is often measured by reduction in thickness, clearing from the proximal nail, and eventual healthy regrowth. This helps set expectations and improves adherence to long treatment courses.

Dealing with toenail onychomycosis requires a deliberate and evidence-based plan. Confirm the diagnosis, choose therapy based on severity and organism, consider oral terbinafine as the usual first-line option for dermatophyte infection, and use topical agents or debridement where appropriate. Equally important are preventive measures that reduce recurrence, including treating tinea pedis, keeping the feet dry, and maintaining nail hygiene. Because the condition is chronic and treatment response is slow, realistic expectations and consistent follow-up are essential for long-term success.

The assessment of the diabetic foot is fundamentally aimed at identifying patients at risk of ulceration, infection, and amputation before tissue breakdown occurs. Neuropathy is central to that process, because loss of protective sensation, impaired autonomic function, and altered biomechanics all increase plantar loading and reduce the foot’s ability to defend itself. Neuropad has attracted interest because it offers a simple bedside method of detecting one important component of diabetic neuropathy: sudomotor dysfunction. By measuring the skin’s ability to change colour in response to sweat, it provides an indirect marker of sympathetic cholinergic small-fibre function.

Neuropad is applied to the plantar surface of the foot, typically over the great toe or forefoot region, and the result is read after a set period according to the degree and speed of colour change from blue to pink. In healthy skin, the plaster changes colour relatively quickly because sweating is intact. When the colour change is delayed, incomplete, or absent, this suggests reduced sweating and therefore autonomic neuropathy. This mechanism is clinically relevant because autonomic neuropathy contributes to dry, brittle skin and higher vulnerability to cracking and ulceration, especially in patients with diabetes who already have pressure-related risk factors.

The main strength of Neuropad is practicality. It is non-invasive, easy to perform, inexpensive, and does not require advanced equipment or specialised neurophysiology training. These features make it attractive in primary care, podiatry, and other outpatient settings where rapid risk stratification is needed. A meta-analysis of 18 diagnostic studies involving 3470 participants found average sensitivity of 86% and specificity of 65%, supporting its role as a triage test that can help rule out the “foot at risk” when negative. The same review concluded that patients with a positive result should be referred for more specialised assessment to establish a definite diagnosis.

A further advantage is that Neuropad appears to assess small-fibre dysfunction relatively well. In a comparative study of diabetic patients, its accuracy was stronger against corneal nerve fibre length, a marker of small-fibre damage, than against traditional large-fibre tests such as neuropathy disability score, vibration perception threshold, and motor nerve conduction velocity. This matters because early diabetic neuropathy often involves small fibres first, including autonomic fibres, before conventional bedside tests become clearly abnormal. In that sense, Neuropad may detect an earlier stage of neuropathic change than routine large-fibre-focused screening alone.

There is also evidence linking Neuropad to clinical ulcer risk. In one study of type 2 diabetes, the time to complete colour change performed better than 10 g monofilament testing in predicting diabetic foot ulcer risk, with an area under the ROC curve of about 0.8 and a suggested cut-off around 22.25 minutes. This supports the idea that sudomotor impairment is not merely a laboratory marker but has practical value in identifying patients more likely to develop foot complications. Another study in patients with diabetic foot ulceration found that Neuropad was a reliable and easy-to-use test for autonomic neuropathy, which was associated with greater ulceration and amputation risk.

However, Neuropad has important limitations. Its specificity is only moderate, so a positive result does not confirm neuropathy on its own and may produce false positives. It should therefore be interpreted within a full diabetic foot assessment that includes history, inspection, vascular assessment, monofilament or other sensory testing, footwear review, and biomechanical evaluation. The test also does not replace formal neurological examination, and the evidence base has been criticised for risk of bias and uncertainty about patient-important outcomes such as ulcer prevention, cost-effectiveness, and impact on long-term management. For these reasons, Neuropad is best viewed as an adjunctive screening tool rather than a definitive diagnostic test.

In clinical practice, the most defensible use of Neuropad is as part of a layered risk-assessment strategy. A negative result can add reassurance when the overall clinical picture suggests low risk, while an abnormal result can strengthen the case for closer surveillance, patient education, pressure management, and referral for comprehensive neuropathy evaluation. In a podiatry or diabetes clinic, this may be especially useful where there is concern about early autonomic involvement, dry skin, recurrent callus, or unexplained fissuring, all of which can precede ulceration. Its simplicity also makes it attractive for self-testing and community-based screening, although that should not substitute for professional foot surveillance.

Overall, Neuropad has a clear place in the assessment of the diabetic foot as a simple indicator of sudomotor dysfunction and small-fibre neuropathy. Its best role is as a screening or triage tool that helps identify patients needing more detailed evaluation, rather than as a standalone diagnostic endpoint. In an era where diabetic foot complications remain a major cause of morbidity, a test that is quick, non-invasive, and reasonably sensitive can be clinically valuable if used appropriately within a broader assessment framework.[

Mycetoma affecting the foot is a chronic, progressively destructive infection that usually begins after traumatic implantation of bacteria or fungi into skin and soft tissue. It commonly presents with a painless swelling of the foot, sinus tracts that drain pus, and visible “grains” in the discharge, and if diagnosis is delayed it can invade bone and lead to severe deformity or amputation

Mycetoma is an important tropical and subtropical disease because it often affects people who work barefoot in rural environments and may not seek care until the disease is advanced. The foot is the classic site of infection, likely because it is frequently exposed to thorn pricks, splinters, and other minor penetrating injuries that introduce organisms from soil or plant matter into deeper tissues. Although the disease is not common in many parts of the world, it has major consequences for mobility, work capacity, and quality of life. For a condition that often starts quietly, its later effects can be devastating.

Cause and transmission

Mycetoma is caused by either bacteria or fungi, which leads to two broad forms: actinomycetoma and eumycetoma. The organisms are usually environmental, living in soil, water, or plant material, and infection typically follows a break in the skin rather than person-to-person spread. Minor injuries such as stepping on a thorn or wood splinter are classic triggers, especially in settings where shoes are not regularly worn. The disease is therefore closely tied to occupation, poverty, and limited access to preventive footwear and healthcare. This makes mycetoma more than an infection; it is also a marker of social vulnerability.

Clinical features

The hallmark of foot mycetoma is a slowly enlarging, usually painless swelling that may persist for months or years before diagnosis. Over time, the lesion can develop multiple draining sinuses that discharge thick material containing tiny grains, which may be white, yellow, red, brown, or black depending on the causative organism. Because pain is often minimal, many patients continue walking and working while the lesion gradually expands. As the disease progresses, the foot may become distorted, stiff, or functionally unusable, and secondary bacterial infection can complicate the picture. In advanced cases, underlying muscle, tendons, and bone may be destroyed.

Diagnosis

Diagnosis of foot mycetoma depends on a combination of clinical suspicion, imaging, and laboratory confirmation. A careful history of barefoot exposure, thorn injury, rural work, and very slow progression should raise suspicion early. Imaging such as ultrasound or X-ray can help assess the extent of soft tissue involvement and detect bone invasion, while biopsy, aspiration, or examination of the grains can identify the organism. This distinction matters because actinomycetoma and eumycetoma require different treatment approaches. Delayed diagnosis is common because the condition may mimic chronic abscesses, osteomyelitis, or other granulomatous foot disorders.

Treatment

Treatment depends on whether the infection is bacterial or fungal. Actinomycetoma usually responds better to prolonged antibiotic therapy, while eumycetoma generally requires long-term antifungal treatment, often with itraconazole or related agents. Surgery may be needed when there is extensive local disease, failure of medical therapy, or significant bone involvement. In late or severe cases, bone resection or even amputation may be required to control the infection and preserve overall function. Because treatment is prolonged and relapses can occur, adherence and follow-up are essential. Outcomes are best when the disease is caught before major tissue destruction has occurred.

Public health impact

Foot mycetoma has a disproportionate effect on people in endemic regions of Africa, Latin America, and Asia, especially farmers, herders, and other outdoor workers. The disease can cause long-term disability, lost income, and stigma, particularly when deformity becomes visible. Prevention is therefore straightforward in principle but difficult in practice: wearing protective shoes, promptly cleaning wounds, and seeking early evaluation after penetrating foot injuries can reduce risk. However, these measures are harder to implement where poverty, remote geography, and limited healthcare access persist. This is one reason mycetoma is recognized as a neglected tropical disease

Conclusion

Mycetoma of the foot is a chronic infection that begins innocently but can become highly destructive if not recognized early. Its classic triad of painless swelling, draining sinuses, and grains in discharge should prompt urgent evaluation, especially in people from endemic regions or those with barefoot exposure. Because treatment differs for bacterial and fungal disease, accurate diagnosis is critical, and early therapy offers the best chance of preventing deformity, disability, and amputation. In clinical practice, the key challenge is not just treating mycetoma, but diagnosing it before the foot is irreversibly damaged.

Onychomycosis, commonly known as fungal nail infection, affects up to 10-20% of adults, particularly in the feet, where toenails are more prone due to environmental exposure and trauma. Laser therapy has emerged as a promising alternative to traditional treatments, targeting fungi embedded in the nail plate via photothermolysis.

Understanding Onychomycosis

Onychomycosis primarily impacts toenails, caused by dermatophytes like Trichophyton rubrum, yeasts, or molds. In podiatry, distal lateral subungual onychomycosis (DLSO) is most common in feet, featuring nail discoloration, thickening, and crumbling, often leading to pain during walking or footwear use. Risk factors include diabetes, immunosuppression, athletic activities like golf, and occlusive footwear prevalent in Melbourne’s variable climate. Diagnosis requires mycological confirmation via KOH prep or culture, distinguishing it from psoriasis or trauma.

Conventional Treatments and Limitations

Oral antifungals like terbinafine achieve 70-85% mycological cure but risk hepatotoxicity and drug interactions, unsuitable for many podiatry patients with comorbidities. Topical agents penetrate poorly, yielding <20% cure rates, while mechanical debridement alone recurs frequently. These limitations drive demand for non-pharmacological options in foot care, where patient compliance is key for athletes or professionals.

Mechanism of Laser Therapy

Laser treatment employs selective photothermolysis, where specific wavelengths heat fungal elements to 40-60°C, disrupting cell walls without damaging surrounding tissue. Nd:YAG (1064 nm) targets melanin in fungal hyphae, penetrating deeply into the nail bed ideal for thick toenails. CO2 lasers (10,600 nm) ablate infected tissue via vaporization, enhancing drug permeation when combined. Low-level lasers like Lunula (635/405 nm) stimulate antifungal activity non-thermally, FDA-cleared for safety.

Types of Lasers Used

Common podiatry lasers include long-pulsed Nd:YAG (1064 nm), with 63-71% mycological cure; short-pulsed variants at 21%; and CO2 fractional/perforated at 45-95%. Lunula offers 80% success painlessly, treating all toenails in 30 minutes. Dual-wavelength Q-switched Nd:YAG (1064/532 nm) suits mild cases, improving clearance in non-dermatophyte infections. CO2 excels in severe DLSO but risks eschar formation

Clinical Efficacy Evidence

A 2019 meta-analysis of 35 studies (1723 patients, 4278 nails) reported 63% overall mycological cure for lasers, with CO2 at 74% outperforming others. Nd:YAG matches terbinafine efficacy (63%) but with fewer side effects, per 2024 reviews. Podiatry clinics report 70-90% improvement, superior to topicals, though full regrowth takes 6-12 months due to slow toenail growth (1 mm/month). Combination with topicals boosts rates to >80%.

Treatment Protocols in Podiatry

Podiatrists debride nails to <2 mm thickness first, enhancing penetration. Typical Nd:YAG protocol: 4-12 weekly sessions (e.g., 1064 nm, 4 J/cm², 30 ms pulse), 30 minutes total. Lunula: 4 bi-weekly exposures, no prep needed. CO2: 3-4 sessions at 3-week intervals, 30W for fractional ablation. Follow-up includes monthly cultures; maintenance for high-risk feet like diabetics. Australian TGA approves Lunula for onychomycosis.completepodiatry+5

Advantages and Safety Profile

Lasers offer pain-free (or mild warmth), no-downtime sessions, ideal for active podiatry patients. Safety is high; adverse events limited to transient pain (tolerable), rare bleeding, or erythema.<] Unlike orals, no systemic risks, suiting elderly or liver-compromised individuals common in foot clinics. Precision spares matrix, preserving biomechanics for gait.

Comparison to Other Modalities

Treatment	Mycological Cure Rate	Sessions/Duration	Side Effects	Cost (AU est.)	Podiatry Suitability
Oral Terbinafine pmc.ncbi.nlm.nih+1	75-85%	12 weeks daily	Hepatotoxicity (5%)	$100-200	Contraindicated in many
Topical (e.g., Amorolfine) southcarolinablues	10-40%	12 months weekly	Minimal	$50-100	Poor penetration
Nd:YAG Laser pmc.ncbi.nlm.nih+1	63-71%	4-12 weekly	Mild pain (<5%)	$500-1500/course	High; quick compliance
CO2 Laser pmc.ncbi.nlm.nih+1	74-95%	3-4 at 3 weeks	Bleeding (rare)	$800-2000	Ablative; severe cases
Lunula LLLT foothealthclinic+1	~80%	4 bi-weekly	None	$400-800	Painless; all nails

Lasers excel in efficacy/safety balance for foot onychomycosis.

Limitations and Future Directions

Recurrence (10-20%) persists without hygiene; severe matrix damage resists treatment. Evidence gaps include long-term RCTs (>1 year) and cost-effectiveness in podiatry. Ongoing trials explore combos like laser + tazarotene for enhanced clearance. In Australia, integration into CPD supports evidence-based use.

Laser treatment revolutionizes podiatric management of foot onychomycosis, balancing efficacy, safety, and convenience for diverse patients.

Pain around the side of a toenail is typically assumed to result from onychocryptosis (an ingrown toenail), where the nail plate pierces the periungual skin. However, lateral nail fold pain can exist in the absence of true nail plate penetration. Understanding the underlying non-ingrown causes requires an appreciation of the complex anatomy of the nail unit and surrounding soft tissues, as well as recognition of mechanical, dermatological, neurological, and systemic influences.

Nail Unit Anatomy and Biomechanical Considerations

The toenail apparatus includes the nail plate, nail bed, nail matrix, hyponychium, and lateral and proximal nail folds. The great toe bears significant load during gait, with lateral pressure increasing during propulsion and toe-off phases. Chronic, repetitive microtrauma or footwear-related compression can produce pain at the lateral nail fold even without nail embedding. This biomechanical component often underlies many “non-ingrown” nail pain syndromes.

For example, ill-fitting shoes that narrow at the toe box can press the nail edge against periungual tissue. Over time, this creates inflammation, mild edema, and tenderness along the nail sulcus, often mistaken for early onychocryptosis. Biomechanical factors such as hallux valgus, digital deformities, or pes planus can redistribute pressure so that the lateral margin of the hallux nail receives greater shear forces during walking.

Common Non-Ingrown Causes

Several distinct clinical entities can explain pain at the side of the toenail without ingrowth:

• Traumatic or repetitive pressure injury: Chronic shoe compression or athletic activity (e.g., running or kicking sports) may irritate the lateral sulcus, leading to focal tenderness and erythema. The nail edge remains intact, but adjacent soft tissue becomes inflamed.
• Nail plate impingement from curvature: Some nails exhibit excessive transverse curvature (pincer nails or involuted nails). Even though the plate does not penetrate the skin, the curving edge can compress periungual tissue and elicit pain from pressure alone.
• Periungual callus or corns: Hyperkeratosis can develop along the nail fold due to chronic friction, producing localized pain that mimics an ingrown nail. In some cases, a nail wall corn (heloma molle or heloma durum) forms in the lateral groove where skin folds consistently rub together.
• Paronychia (without ingrowth): Acute or chronic paronychia may occur secondary to bacterial or fungal infection in the nail fold. Chronic paronychia often presents with swelling, tenderness, and erythema of the nail border, typically linked to moisture exposure or irritant damage weakening the cuticle barrier.
• Onychophosis: The accumulation of hyperkeratotic debris between the nail plate and lateral fold can produce significant discomfort, erosions, and inflammation, particularly in elderly patients or those wearing constrictive shoes. The condition is common and often overlooked.
• Psoriasis or eczema involving the nail folds: Inflammatory dermatoses may affect periungual tissues, causing erythema, scaling, and pain. Nail psoriasis may coexist with subungual hyperkeratosis or pitting, leading patients to attribute discomfort mistakenly to a mechanical cause.
• Subungual exostosis or osteochondroma: A benign bony outgrowth beneath the distal nail bed can elevate part of the nail plate, altering local pressure distribution. This causes localized tenderness, especially along the lateral edge, sometimes before visible nail change occurs.
• Neuropathic pain: Localized nerve irritation, such as from trauma or peripheral neuropathy, may manifest as burning or shooting pain around the nail despite normal skin and nail appearance.
• Foreign body or micro-splinter: Tiny fragments (e.g., sock fibres or debris from pedicures) can lodge beneath the lateral sulcus, provoking inflammatory reactions without clear external entry sites.

Diagnostic Approach

Accurate diagnosis begins with careful clinical assessment and differentiation between mechanical, inflammatory, and structural causes. A thorough history and physical examination should note:

• Location and quality of pain (sharp, throbbing, or burning)
• Triggers (e.g., footwear, activity, water exposure, chemical irritants)
• Nail curvature and fold morphology
• Evidence of infection, drainage, or hypertrophic tissue
• Nail plate deformities, thickening, or color change
• Past trauma or history of systemic skin disease

Dermatoscopic or magnified inspection can help distinguish an embedded edge (true ingrown toenail) from non-penetrating variants. Probing gently beneath the nail margin determines whether the nail plate breaches the epithelium. Radiographs may be indicated when subungual exostosis is suspected, especially if chronic pain persists or nail elevation is visible.

In selected cases, microscopy or culture can confirm fungal or bacterial involvement, and a skin scrape or biopsy may help diagnose inflammatory or psoriatic nail disease.

Management Strategies

Management depends on the underlying cause. When ingrown toenail is excluded, conservative approaches generally focus on relieving pressure, reducing inflammation, and addressing contributing biomechanical or dermatological factors.

1. Footwear modification

Wider toe-box shoes are often the simplest and most effective intervention. They decrease lateral nail fold compression and prevent further microtrauma. Patients should avoid tight-fitting dress shoes or narrow sports footwear.

2. Nail care and debridement

Reducing nail plate thickness and curvature via professional podiatric care can relieve pressure. Careful removal of onychophosis or hyperkeratotic debris from the lateral groove often gives immediate pain relief. Emollients containing urea (10–25%) can soften keratotic build-up, while antiseptic or antifungal preparations may help manage chronic paronychia.

3. Padding and protective devices

Silicone toe sleeves, digital spacers, or custom padding can offload pressure from the affected fold. For individuals with structural deformities, orthoses or footwear adjustments targeting forefoot loading patterns may prevent recurrence.

4. Management of infection and inflammation

Topical antiseptics (e.g., povidone-iodine) or topical antibiotics can treat localized bacterial infection. Inflammatory dermatoses such as psoriasis or eczema respond to topical corticosteroids or calcineurin inhibitors applied to the periungual skin. Chronic paronychia benefits from reducing wet work exposure, applying barrier creams, and maintaining a dry environment.

5. Addressing structural causes

In cases of pincer or involuted nails, gradual flattening techniques such as orthonyxia (nail bracing) may relieve pain and guide normal growth. Surgical nail correction is reserved for severe or recurrent curvature not responsive to conservative measures. Subungual exostosis requires surgical excision once confirmed radiographically.

6. Neuropathic or idiopathic pain

If symptoms appear disproportionate to physical findings, neuropathic mechanisms should be considered. Gabapentin, topical lidocaine, or desensitization strategies may be appropriate in selected cases after ruling out local tissue pathology.

Clinical Vignettes

Consider a 38-year-old runner presenting with lateral border tenderness of the hallux nail, showing no embedding or drainage. The nail curvature is exaggerated, and compression testing elicits pain along the groove. Diagnosis: involuted nail causing pressure on the sulcus. Management with footwear modification, gentle edge thinning, and silicone sleeve resolved symptoms.

A second case involves a 64-year-old gardener with chronic swelling and tenderness along both hallux nail edges. Culture revealed Candida species. Chronic paronychia linked to moisture exposure—treated effectively with topical antifungal therapy and protective gloves during gardening.

Preventive Considerations

Preventing lateral nail fold pain relies on consistent nail and footwear care. Nails should be cut straight across with slightly rounded corners to avoid sharp spicules that can irritate periungual skin. Patients should be advised against aggressive digging or trimming down the sides of nails, as this often initiates inflammation that mimics early onychocryptosis. Regular monitoring is important for athletes, tradespeople, or individuals with deformities altering forefoot load, as they remain at higher risk for recurring periungual pain.

Pain at the side of a toenail does not always equal an ingrown nail. Instead, it encompasses a spectrum of conditions ranging from pressure-induced hyperkeratosis to inflammatory skin disease and neuropathic irritation. Careful assessment guided by nail morphology, surrounding tissue changes, and mechanical influences is essential for distinguishing these aetiologies. Podiatric management should aim to alleviate pressure, correct structural or footwear issues, and treat any infection or inflammation while educating patients on ongoing preventive care.

Understanding these non-ingrown causes of toenail pain broadens diagnostic accuracy and enhances care outcomes, reducing unnecessary procedures and ensuring symptoms are managed at their source.

Ingrown toenails are a common and painful condition in which the edge of a toenail grows into the surrounding skin, most often on the big toe. Effective treatment ranges from simple self‑care at home to minor surgical procedures in a clinic, depending on how severe the problem is and whether infection is present.

What is an ingrown toenail?

An ingrown toenail occurs when the nail plate curves and presses or pierces into the adjacent skin of the nail fold. This causes local inflammation, redness, swelling and tenderness, and can progress to infection with pus and overgrowth of tissue if not managed. People who trim nails too short or rounded, wear tight shoes, or have naturally curved/thick nails are particularly prone to the problem. Recurrent episodes are common if the underlying cause is not corrected.

Mild cases and home treatment

For early or mild ingrown toenails, conservative treatment at home is often sufficient. The aim is to reduce inflammation, relieve pressure from the nail edge, and guide the nail to grow straight out rather than into the skin. A typical first step is to soak the foot in warm water for 15 to 20 minutes several times a day, sometimes with Epsom salt or mild soap to soften the skin and nail and to help reduce discomfort. After soaking, gently drying the foot and using a clean cotton bud to nudge the swollen skin away from the nail edge can help free the nail margin.

Some people place a tiny wisp of cotton or dental floss under the very edge of the nail after soaking. This lifts the nail slightly away from the skin so it can grow over, rather than into, the nail fold. The material must be changed daily and kept clean to reduce the risk of infection. During this period, it is important to wear roomy footwear or open‑toed sandals so that there is no extra pressure on the affected toe. Simple pain relievers such as paracetamol or ibuprofen can be used if needed, provided there are no medical reasons to avoid them.

When medical care is needed

If pain is significant, the nail fold looks very red or swollen, there is pus, or home care fails over a few days, professional treatment is recommended. A doctor or podiatrist can confirm the diagnosis and rule out other problems such as fungal nail disease, trauma or, in people with diabetes, more serious infections. They may gently lift the ingrown edge and place a small piece of cotton, dental floss or a specialized splint beneath it to keep it elevated. Sometimes a topical corticosteroid cream is prescribed to reduce inflammation around the nail once the toe has been soaked.

Infected ingrown toenails can require additional measures. If there is spreading redness, warmth extending beyond the toe, or systemic symptoms such as fever, oral antibiotics may be indicated. However, for many localized infections, proper drainage, removal of the offending nail edge and good local wound care are the most important components of treatment. People with poor circulation, diabetes, or immune problems should seek medical help early, as even a minor ingrown toenail can lead to serious complications in these groups.

Surgical treatment options

Moderate to severe or recurrent ingrown toenails are often best managed with minor surgical procedures under local anaesthetic. The most common method is partial nail avulsion, in which the clinician removes a narrow strip from the side of the nail that is growing into the skin. This immediately relieves pressure and allows inflamed tissue to settle. In many cases, this procedure is combined with destruction of the corresponding part of the nail matrix (the root that produces the nail) so that the removed strip does not grow back.

Matrix destruction can be performed chemically, most often by applying phenol, or mechanically by cutting out the matrix tissue or using electrocautery or laser. Chemical matricectomy with phenol after partial nail avulsion has been shown to reduce the risk of the ingrown edge recurring, although it may slightly increase short‑term drainage and risk of minor infection compared with simple excision. Alternative technologies such as radiofrequency or carbon dioxide laser aim to achieve the same result with less bleeding and possibly quicker recovery.

Aftercare and recovery

After a surgical procedure, the toe is usually dressed with a sterile bandage, and patients are advised to rest and keep the foot elevated for the first day. Mild bleeding and oozing can continue for a few days as the area heals. The dressing is typically changed daily or as instructed, with gentle cleaning in warm water and re‑application of a clean, dry bandage. Most people can resume normal walking within a day or two, but tight or restrictive footwear should be avoided until tenderness and swelling subside.

Pain after partial nail avulsion is usually modest and can be controlled with oral pain relievers. The remaining nail often looks slightly narrower than before but generally functions normally and grows out in a way that avoids the previous problem side. It is important to attend any recommended follow‑up appointments so the clinician can check healing and address any early signs of infection or recurrence.

Prevention and long‑term care

Preventing future ingrown toenails is an important part of treatment, especially for those who have had repeated episodes. Correct nail‑cutting technique is central: toenails should be trimmed straight across, with the corners left visible rather than cut into a curve, and not cut excessively short. Using clean, sharp clippers and avoiding tearing or ripping the nail reduces the chance of leaving sharp spikes that can penetrate the skin. Good foot hygiene, including keeping the feet dry and changing socks regularly, helps lower the risk of infection.

Footwear choice also matters. Shoes with a wide toe box that do not compress the toes together, and avoiding high heels or narrow shoes for long periods, can significantly lower pressure on the nails. People engaged in sports that involve repeated toe trauma, such as football, running or ballet, may need specially fitted shoes or protective padding. Those with conditions that impair sensation or circulation, such as diabetes, should have regular foot checks by a health professional and seek early advice at the first sign of nail problems.

In summary, ingrown toenails can usually be treated effectively with a combination of self‑care, conservative clinical measures and, when necessary, minor surgical procedures. Understanding how they develop, knowing when to escalate from home remedies to professional care, and following sound preventive habits are key to reducing pain, infection and recurrence over the long term.

Friar’s balsam, or compound benzoin tincture, is a traditional resin‑based preparation that has persisted into modern practice as a niche but useful topical agent for selected foot conditions. In podiatry it is used far less as a “panacea” than in the past, but remains relevant as both an adhesive enhancer for padding and dressings and as a mild antiseptic and protectant for superficial lesions and fissures.

Composition and pharmacological actions

Friar’s balsam is a solution of benzoin resin in ethanol, with additional balsamic resins such as storax, Tolu balsam and aloe, giving it characteristic antiseptic, astringent and film‑forming properties. The alcohol vehicle facilitates rapid evaporation, leaving a thin resinous film that adheres to the stratum corneum and increases surface tack.

The benzoin and related resins contain esters and free cinnamic and benzoic acids, compounds long associated with weak antimicrobial and antiseptic effects. When applied to intact or minimally disrupted skin, the evaporating alcohol has a transient drying, cleansing effect, while the residual film acts as a protectant, reducing minor friction and contamination over small wounds, fissures or chapped skin. However, these same resins are also well‑recognised contact allergens, which places practical limits on widespread use.

Historical and modern indications

Historically Friar’s balsam was promoted as a near‑universal topical remedy for “wounds of all kinds, bruises, and all skin disorders”, and even taken internally for problems as diverse as worms, haemorrhoids and “cardiac disease”. Contemporary regulatory indications are far narrower, with the product listed in Australia, for example, as an antiseptic for minor cuts and abrasions and as a symptomatic treatment for common colds when inhaled as steam.

For foot care, modern over‑the‑counter descriptions emphasise its use as an antiseptic protectant for minor cuts and abrasions, chapped skin, small skin fissures and bedsores, and to relieve itch associated with chilblains and mild eczematous conditions. In practice this translates to typical podiatric scenarios such as superficial heel fissures, minor interdigital splits, small periungual cracks and low‑grade excoriations where a light, protective barrier is useful but heavy occlusion is undesirable.​

Role as an adhesive enhancer in foot care

Within podiatry and sports medicine, Friar’s balsam is now best known for its role as an adhesive enhancer under taping and padding on the foot. When applied sparingly to clean, dry, intact skin and allowed to dry for 30–60 seconds, compound benzoin tincture markedly increases the bond strength of adhesive tapes, dressings, felt and foam padding, particularly in high‑friction, high‑sweat environments such as the plantar forefoot and heel.

This property is especially valuable in:

• Management of friction blisters: ensuring that prophylactic tapes and hydrocolloid dressings remain adherent on macerated or sweaty skin during running, hiking or field sports.
• Off‑loading corns and calluses: helping semi‑compressed felt or foam pads remain in situ over bony prominences like metatarsal heads or toe dorsum for longer between changes.
• Securing post‑operative or post‑debridement dressings: improving adherence around toes and plantar surfaces where conforming dressings tend to lift.blister-prevention+1​

However, the very stickiness that makes Friar’s balsam useful can also raise local friction if used over too large an area: exposed resin can attract sock fibres and grit as the foot perspires, increasing the coefficient of friction and, paradoxically, the risk of blisters. Clinically, this necessitates highly targeted application limited to the footprint of the intended tape or pad, with any exposed areas dusted with powder or covered to prevent unwanted traction.

Use for fissures, chapping and minor lesions

Product information from several manufacturers highlights Friar’s balsam as a topical protectant for “chapped skin and lips, cracked nipples, small skin fissures and bedsores”, with additional claims of relieving itching in chilblains, eczema and urticaria. Transposing these indications to the foot, potential uses include:

• Small, superficial heel fissures or peri‑fissure skin where a light film may reduce further splitting and contamination once bleeding has ceased.
• Mild periungual cracks or interdigital fissures secondary to irritant dermatitis or cold exposure, if the surrounding skin is otherwise intact.
• Low‑grade chilblain itch on toes, as an adjunct to standard warmth and vascular‑protective measures, noting that the evidence is experiential rather than trial‑based.

Nevertheless, the alcohol base will sting intensely on open blisters, abrasions or actively exuding eczema. Best practice is therefore to restrict application to intact or nearly healed skin around a lesion, and to rely on more conventional emollients, barrier creams and appropriate dressings for substantive fissures, ulcers or dermatitis.

Risks, contraindications and patient selection

The major clinical limitation in using Friar’s balsam on the feet is the risk of dermatitis. Allergic contact dermatitis to the balsamic resins (benzoin, storax, Tolu balsam) is well documented and considered the most important adverse effect, often presenting with delayed pruritic, eczematous eruptions 24–72 hours after exposure. Once sensitised, patients are likely to exhibit cross‑reactivity with other fragrance mixtures and Balsam of Peru, creating persistent difficulties with many cosmetics and topical products.biomedicus​

Irritant contact dermatitis is also possible, driven by the high alcohol content and resin load, and typically presents as immediate burning and erythema at the site of application, particularly on already compromised skin. Product information also notes that frequent or widespread application can cause skin dryness and cracking, an undesirable effect on already vulnerable plantar skin.file2.

Other safety considerations include:

• Avoidance on broken or significantly inflamed skin, given stinging, potential irritancy and theoretical risk of increased systemic absorption.
• Caution in atopic patients or those with known fragrance or Balsam of Peru allergy, where the sensitisation risk is high.
• Avoidance of use as an inhalant in individuals with asthma or significant respiratory disease, due to the potential for bronchospasm.

In podiatric settings, patch‑testing a small area before wider use may be prudent in patients with complex dermatological histories, and practitioners should counsel patients to discontinue use and seek review if any rash, intense itching or blistering develops.

Place of Friar’s balsam in contemporary podiatry

In modern evidence‑based foot care, Friar’s balsam occupies a modest, adjunctive role rather than a central therapeutic position. Its primary contemporary value lies in:

• Enhancing the adherence and durability of tapes, dressings and off‑loading pads in challenging high‑moisture, high‑friction environments such as athletic or occupational feet.
• Providing mild antiseptic and protective film effects for minor, superficial lesions and fissures, when used judiciously on nearly intact skin.

Balanced against this are the relatively high rates of irritant and allergic contact dermatitis and the availability of alternative adhesive enhancers and barrier products (such as colourless skin‑prep wipes) that may offer similar benefits with less mess and potentially lower allergenicity. For the podiatric clinician, Friar’s balsam is therefore best considered a specialised tool: useful in selected patients and specific foot‑care scenarios, but always deployed with restraint, targeted application and awareness of its sensitising potential.

Foot odour is usually very treatable with good hygiene, smart footwear choices, and a few simple home or medical remedies. An effective 1000‑word essay on treating foot odour should explain what causes the smell, how to change daily habits, which treatments work at home, and when to see a health professional for further help.

Understanding foot odour

Foot odour (bromodosis) develops when sweat from the feet is broken down by skin bacteria into strong‑smelling acids. Sweat itself is odourless, but closed shoes, synthetic socks and long hours on your feet trap moisture and create a warm, damp environment where bacteria and sometimes fungi thrive.

Several factors increase the risk of smelly feet, such as naturally sweaty feet, hormonal changes in teenagers, pregnancy, and medical conditions like hyperhidrosis that cause excessive sweating. Re‑wearing shoes without letting them dry, not washing or drying feet properly, and leaving dead, hard skin on the soles give bacteria more surfaces and “food” to grow on, which intensifies the smell.

Daily hygiene measures

Treating foot odour starts with consistent hygiene, because reducing sweat and bacteria directly reduces odour. Feet should be washed at least once daily with soap and water, paying special attention to between the toes, then dried thoroughly, especially in those spaces where moisture easily lingers.

Removing thick or hard skin with a pumice stone or foot file once or twice a week helps because soggy, softened callus provides an ideal home for bacteria. Keeping toenails short and clean removes trapped dirt and sweat, and using a clean towel for the feet and changing it frequently prevents re‑introducing bacteria each day.

Home treatments and products

Simple foot soaks are a common and effective home treatment that can be added to daily washing. Epsom salt soaks, typically half a cup of salt in warm water for 10–20 minutes, draw moisture out of the skin and make it harder for bacteria to flourish on the feet.

Vinegar soaks made with one part white or apple‑cider vinegar to two parts warm water once or twice a week can make the skin surface more acidic and less friendly to bacteria, though they should be avoided on broken or irritated skin. Some podiatry resources also suggest tea soaks containing tannic acid, which can mildly tighten the skin and reduce sweating, but these should be used cautiously in people with sensitive skin.

Footwear, socks, and shoe care

Changing what is worn on the feet is just as important as washing, because shoes and socks often hold most of the moisture and bacteria. Socks made of natural or moisture‑wicking fibres, changed at least once a day or more often if they become damp, help keep feet drier than thin synthetic socks that trap sweat.

Shoes should be rotated so each pair can dry fully for at least 24 hours before being worn again, and open‑toed or breathable shoes are better choices in warm weather. Spraying the inside of shoes and removable insoles with an antibacterial or disinfectant spray and allowing them to dry thoroughly helps kill lingering bacteria, while storing shoes in a dry, ventilated, sunny area further discourages bacterial growth.

Medical help and prevention

When home measures do not control the smell, or when there is redness, itching, cracking skin or pain, professional assessment is important. Persistent odour can signal fungal infections such as athlete’s foot, nail fungus, or underlying conditions like diabetes and hyperhidrosis, which may need prescription creams, stronger antiperspirants, or other targeted treatments.

Long‑term prevention focuses on maintaining the same good habits that treat the problem: regular washing and drying, routine exfoliation, clean socks and rotating shoes, and occasional soaks or use of foot antiperspirants if sweating is heavy. By combining hygiene, appropriate footwear, and timely medical advice when needed, most people can control foot odour effectively and keep their feet comfortable and socially acceptable in day‑to‑day life.